ArticleDermatology reports2026
Cutaneous Rosai-Dorfman disease: a case report of disease limited only to skin.
Article in Dermatology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diagnostic consideration of lipoma-like lesion: A case report of primary cutaneous Rosai-Dorfman disease.International journal of surgery case reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rosai-Dorfman disease (RDD) is a disorder of histiocytic proliferation that can affect almost every organ. Skin may be involved in about 10% of cases, but only 3% of patients have skin lesions exclusively. Patients with cutaneous Rosai-Dorfman disease (CRDD) are usually healthy, without leading constitutional or other symptoms. The etiology of this disease is unclear, but it might be triggered by an infectious agent such as herpesvirus 6 (HHV-6) and Epstein-Barr virus (EBV). There is also a predisposition to autoimmune diseases and hematological malignancies. There is also a recognized predisposition to autoimmune disorders and hematologic malignancies. In our case, the patient was diagnosed with an infection due to Borrelia burgdorferi. To our knowledge, no previously reported association between B. burgdorferi infection and RDD has been described. The disease may manifest in any age group. The differential diagnosis includes Langerhans cell histiocytosis, metastasis, Hodgkin's lymphoma, and other diseases. Disease usually resolves spontaneously over a period of months to years. Treatment should be administered in non-responsive or multiple relapsing cases. Also, it is very important to take into consideration the patient's expectations and aesthetic appearance before making a treatment decision. Various treatment options are described, including surgical excision, cryotherapy, corticosteroids, antibiotics, methotrexate, and dapsone. In our case, we used CO2 laser treatment successfully. To our knowledge, this is only the second case where CRDD lesions were treated successfully with CO2 laser.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.